Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment

Addiction Research and Theory

Volumn 19, Issue 4, 2011, Pages 375-379

  Fraser, Suzanne ^a   Moore, David ^b  

^a MONASH UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

harm reduction; hepatitis C; medicalisation

Indexed keywords

EID: 79959442396     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.3109/16066359.2010.530716     Document Type: Conference Paper

References (30)

1. Australian Government Department of Health and Ageing (2005). National hepatitis C strategy 2005-2008. Canberra, Australia: Commonwealth of Australia. Retrieved from http:// www.health.gov.au/internet/main/publishing.nsf/Content/ phd-hepc-strategy-0508-cnt.htm
2. Ballard K., & Elston M.A. (2005). Medicalisation: A multidimensional concept. Social Theory and Health, 3, 228-241.
3. Barad K. (2007). Meeting the universe halfway: Quantum physics and the entanglement of matter and meaning. Durham and London: Duke University Press.
4. Bourgois P., Prince B., & Moss A. (2004). The everyday violence of hepatitis C among young women in who inject drugs in San Francisco. Human Organization, 63, 253-264. (Pubitemid 39437329)
5. Bourgois P., & Schonberg J. (2009). Righteous dopefiend. Berkeley, CA: University of California Press.
6. Conrad P., & Schneider A.W. (1980). Deviance and medicalisation: From badness to sickness. St Louis: Mosby.
7. Cook C., & Kanaef N. (2008). The global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics. London: International Harm Reduction Association.
8. Davis M., & Rhodes T. (2004). Managing seen and unseen blood associated with drug injcting: Implications for theorising harm reduction for viral risk. International Journal of Drug Policy, 15, 377-384. (Pubitemid 39488227)
9. Family Drug Support (2002). Infectious disease prevention - safe injecting and safe sex practices. Retrieved from http:// www.fds.org.au/pdf/ FactSheet9-ID&IP.pdf
10. Fraser S. (2004). 'It's your life!': Injecting drug users, individual responsibility and hepatitis C prevention. Health, 8, 199-221. (Pubitemid 38392438)
11. Fraser S. (2010). Hepatitis C and the limits of medicalisation and biological citizenship for people who inject drugs. Addiction Research and Theory, 18, 544-556.
12. Hathaway A.D. (2002). From harm reduction to human rights: Bringing liberalism back into drug reform debates. Drug and Alcohol Review, 21, 397-404.
13. Hathaway A.D. (2005). Ushering in another harm reduction era? Discursive authenticity, drug policy and research. Drug and Alcohol Review, 24, 549-550. (Pubitemid 43000461)
14. Hopwood M., & Treloar C. (2005). The experience of interferon-based treatments for hepatitis C infection. Qualitative Health Research, 15, 635-646. (Pubitemid 41358776)
15. Hopwood M., Treloar C., & Redsull L. (2006). Experiences of hepatitis C treatment and its management: What some patients and health professionals say. Sydney: National Centre in HIV Social Research, University of New South Wales.
16. Koester S.K. (1994). Copping, running, and paraphernalia laws: Contextual variables and needle risk behavior among injection drug users in Denver. Human Organization, 53, 287-295.
17. Latour B. (2005). Reassembling the social: An introduction to actor-network-theory. Oxford: Oxford University Press.
18. Law J. (2004). After method: Mess in social science research. London and New York, NY: Routledge.
19. Lupton D. (1997). Foucault and the medicalisation critique. In A. Petersen & R. Bunton (Eds.), Foucault, health and medicine (pp. 94-110). London and New York, NY: Routledge.
20. Maher L., & Dixon D. (1999). Policing and public health: Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology, 39, 488-512.
21. Martin A., Vickerman P., & Hickman M. (2010, May 20). Can HCV treatment of active injecting drug users (IDUs) lead to a reduction in HCV transmission? A modelling analysis. Paper presented at the Burnet Institute, Melbourne, Australia.
22. Miller P.G. (2001). A critical review of the harm minimization ideology in Australia. Critical Public Health, 11, 167-178.
23. Mol A. (1999). Ontological politics: A word and some questions. In J. Law & J. Hassard (Eds.), Actor network theory and after (pp. 74-89). Oxford: Blackwell.
24. Mol A. (2002). The body multiple: Ontology in medical practice. Durham and London: Duke.
25. Mol A., & Law J. (2002). Complexities: An introduction. In J. Law & A. Mol (Eds.), Complexities: Social studies of knowledge practices (pp. 1-22). Durham and London: Duke.
26. Moore D. (2004). Governing street-based injecting drug users: A critique of heroin overdose prevention in Australia. Social Science and Medicine, 59, 1547-1557. (Pubitemid 38891420)
27. Moore D., & Fraser S. (2006). Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science and Medicine, 62, 3035-3047.
28. Porter R. (1997). The greatest benefit to mankind: A medical history of humanity. London: HarperCollins.
29. Tomes N. (2007). Patient empowerment and the dilemmas of late-modern medicalisation. Lancet, 369, 698-700. (Pubitemid 46281316)
30. Turner B.S. (1995). Medical power and social knowledge (2nd ed.). London: Sage.